Omeros Corporation (OMER)
USD 6.72
(14.59%)
USD 6.72
(14.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 331.17 Million USD | 7.09% |
| 2022 | 331.01 Million USD | 34.0% |
| 2021 | 247.03 Million USD | 1020.27% |
| 2020 | 22.05 Million USD | -32.64% |
| 2019 | 32.73 Million USD | -77.51% |
| 2018 | 145.58 Million USD | 79.27% |
| 2017 | 81.21 Million USD | 4.81% |
| 2016 | 77.48 Million USD | 59.84% |
| 2015 | 48.47 Million USD | 49.83% |
| 2014 | 32.35 Million USD | 69.27% |
| 2013 | 19.11 Million USD | 2.86% |
| 2012 | 18.58 Million USD | 20.35% |
| 2011 | 15.44 Million USD | 138.4% |
| 2010 | 6.47 Million USD | -45.74% |
| 2009 | 11.93 Million USD | 202.38% |
| 2008 | 3.94 Million USD | 180.33% |
| 2007 | -4.91 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 470.31 Million USD | 32.68% |
| 2024 Q2 | 442.23 Million USD | -5.97% |
| 2023 Q3 | 310.23 Million USD | -7.32% |
| 2023 Q4 | 354.47 Million USD | 14.26% |
| 2023 Q1 | 337.64 Million USD | 2.0% |
| 2023 FY | 354.47 Million USD | 7.09% |
| 2023 Q2 | 334.75 Million USD | -0.86% |
| 2022 Q2 | 328.88 Million USD | -1.28% |
| 2022 Q3 | 197.22 Million USD | -40.03% |
| 2022 Q4 | 331.01 Million USD | 67.83% |
| 2022 FY | 331.01 Million USD | 34.0% |
| 2022 Q1 | 333.16 Million USD | 34.87% |
| 2021 Q2 | 336.16 Million USD | 0.42% |
| 2021 FY | 247.03 Million USD | 1020.27% |
| 2021 Q4 | 247.03 Million USD | -27.55% |
| 2021 Q3 | 340.98 Million USD | 1.44% |
| 2021 Q1 | 334.74 Million USD | 1418.03% |
| 2020 Q2 | 195.65 Million USD | 3.73% |
| 2020 Q3 | 245.2 Million USD | 25.33% |
| 2020 FY | 22.05 Million USD | -32.64% |
| 2020 Q4 | 22.05 Million USD | -91.01% |
| 2020 Q1 | 188.62 Million USD | 476.15% |
| 2019 Q1 | 176.26 Million USD | 21.07% |
| 2019 FY | 32.73 Million USD | -77.51% |
| 2019 Q4 | 32.73 Million USD | 43.29% |
| 2019 Q3 | 22.84 Million USD | -87.16% |
| 2019 Q2 | 178.01 Million USD | 0.99% |
| 2018 Q2 | 127.47 Million USD | 51.11% |
| 2018 Q1 | 84.36 Million USD | 3.88% |
| 2018 FY | 145.58 Million USD | 79.27% |
| 2018 Q4 | 145.58 Million USD | 12.45% |
| 2018 Q3 | 129.46 Million USD | 1.56% |
| 2017 Q3 | 82.12 Million USD | 4.78% |
| 2017 Q2 | 78.37 Million USD | -1.35% |
| 2017 Q1 | 79.44 Million USD | 2.53% |
| 2017 FY | 81.21 Million USD | 4.81% |
| 2017 Q4 | 81.21 Million USD | -1.1% |
| 2016 Q3 | 60.18 Million USD | -8.03% |
| 2016 Q1 | 49.06 Million USD | 1.21% |
| 2016 FY | 77.48 Million USD | 59.84% |
| 2016 Q4 | 77.48 Million USD | 28.75% |
| 2016 Q2 | 65.43 Million USD | 33.37% |
| 2015 Q1 | 31.48 Million USD | -2.69% |
| 2015 FY | 48.47 Million USD | 49.83% |
| 2015 Q4 | 48.47 Million USD | 73.44% |
| 2015 Q3 | 27.95 Million USD | -0.92% |
| 2015 Q2 | 28.21 Million USD | -10.4% |
| 2014 FY | 32.35 Million USD | 69.27% |
| 2014 Q4 | 32.35 Million USD | 1.77% |
| 2014 Q3 | 31.79 Million USD | 3.1% |
| 2014 Q2 | 30.83 Million USD | -2.55% |
| 2014 Q1 | 31.64 Million USD | 65.56% |
| 2013 FY | 19.11 Million USD | 2.86% |
| 2013 Q4 | 19.11 Million USD | -0.68% |
| 2013 Q2 | 18.57 Million USD | -1.79% |
| 2013 Q1 | 18.91 Million USD | 1.79% |
| 2013 Q3 | 19.24 Million USD | 3.59% |
| 2012 Q3 | 13.99 Million USD | 50.66% |
| 2012 FY | 18.58 Million USD | 20.35% |
| 2012 Q2 | 9.28 Million USD | 663.11% |
| 2012 Q4 | 18.58 Million USD | 32.81% |
| 2012 Q1 | 1.21 Million USD | -92.12% |
| 2011 Q4 | 15.44 Million USD | -0.25% |
| 2011 FY | 15.44 Million USD | 138.4% |
| 2011 Q3 | 15.47 Million USD | -4.18% |
| 2011 Q2 | 16.15 Million USD | -1.13% |
| 2011 Q1 | 16.33 Million USD | 152.26% |
| 2010 Q4 | 6.47 Million USD | 5.42% |
| 2010 Q2 | 7.27 Million USD | -31.84% |
| 2010 FY | 6.47 Million USD | -45.74% |
| 2010 Q1 | 10.66 Million USD | -10.66% |
| 2010 Q3 | 6.14 Million USD | -15.49% |
| 2009 FY | 11.93 Million USD | 202.38% |
| 2009 Q4 | 11.93 Million USD | -5.46% |
| 2009 Q3 | 12.62 Million USD | -9.22% |
| 2009 Q2 | 13.9 Million USD | 0.0% |
| 2008 Q4 | 3.94 Million USD | 0.0% |
| 2008 FY | 3.94 Million USD | 180.33% |
| 2007 FY | -4.91 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -23.67 Million USD | 1498.725% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 3976.497% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 5563.147% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -2401.518% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 236.645% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 695.49% |
| Agenus Inc. | 274.13 Million USD | -20.807% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4220.626% |
| GlycoMimetics, Inc. | -40.98 Million USD | 908.053% |
| Novavax, Inc. | -298.29 Million USD | 211.023% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 204.57% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 2178.554% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 187.801% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -52635.032% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -440.634% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 82.289% |
| AlloVir, Inc. | -62.69 Million USD | 628.259% |
| Aptorum Group Limited | 1.35 Million USD | -24304.184% |
| Ardelyx, Inc. | 34.51 Million USD | -859.597% |
| Bicycle Therapeutics plc | -481.46 Million USD | 168.785% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -815.787% |
| Chimerix, Inc. | -25.51 Million USD | 1397.864% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -4652.761% |
| CRISPR Therapeutics AG | -150.84 Million USD | 319.547% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -2251.935% |
| Precision BioSciences, Inc. | -85.41 Million USD | 487.749% |
| Dyadic International, Inc. | -6.37 Million USD | 5292.394% |
| Elevation Oncology, Inc. | -19.11 Million USD | 1832.273% |
| Fortress Biotech, Inc. | 7.66 Million USD | -4220.626% |
| GT Biopharma, Inc. | -1.02 Million USD | 32536.435% |
| Alkermes plc | -166.73 Million USD | 298.619% |
| Immix Biopharma, Inc. | -17.5 Million USD | 1991.376% |
| Innoviva, Inc. | 255.56 Million USD | -29.587% |
| IO Biotech, Inc. | -140.69 Million USD | 335.379% |
| Jaguar Health, Inc. | 29.39 Million USD | -1026.794% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 2072.577% |
| ContextLogic Inc. | -232 Million USD | 242.748% |
| AbCellera Biologics Inc. | -55.94 Million USD | 692.02% |
| Lantern Pharma Inc. | -21.7 Million USD | 1625.926% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 6846.303% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -7637.757% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -1816.75% |
| MEI Pharma, Inc. | -3.7 Million USD | 9038.623% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 356.499% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1888.221% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 3342.373% |
| NextCure, Inc. | -6.47 Million USD | 5213.108% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 399.606% |
| ChromaDex Corporation | -24.04 Million USD | 1477.146% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 314.846% |
| Incyte Corporation | -3.17 Billion USD | 110.43% |
| Opthea Limited | 28.15 Million USD | -1076.158% |
| MiMedx Group, Inc. | -33.9 Million USD | 1076.892% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -2622.755% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 692.825% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -4703.413% |
| Vaxcyte, Inc. | -368.22 Million USD | 189.938% |
| PDS Biotechnology Corporation | -32.7 Million USD | 1112.495% |
| Pharming Group N.V. | 109.8 Million USD | -201.606% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 2003.748% |
| Onconetix, Inc. | 5.33 Million USD | -6111.759% |
| Acelyrin, Inc. | -216.9 Million USD | 252.684% |
| PureTech Health plc | -167.19 Million USD | 298.075% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -3148.416% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 288.995% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 14393.144% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 1888.221% |
| ESSA Pharma Inc. | -33.62 Million USD | 1085.01% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -1091.581% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 755.781% |
| Seer, Inc. | -4.24 Million USD | 7910.755% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 4764.451% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 19309.745% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 5751.468% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 6003.035% |
| Summit Therapeutics Inc. | 34.67 Million USD | -855.113% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 4968.088% |
| Senti Biosciences, Inc. | 1.74 Million USD | -18933.103% |
| ImmuCell Corporation | 10.99 Million USD | -2913.276% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 527.594% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -6105.284% |
| Precigen, Inc. | -481 Thousand USD | 68951.559% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 2490.127% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 5291.66% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 279.395% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -104.756% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -331842.788% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -198.707% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 1477.776% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 382.945% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 1187.249% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -2547.079% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 296.856% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -437.048% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 4459.874% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 588.583% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 347.001% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 1247.049% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 439710.269% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 1173.087% |
| Aptose Biosciences Inc. | -8.19 Million USD | 4141.266% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 10684.023% |
| Soligenix, Inc. | -4.95 Million USD | 6788.266% |
| Century Therapeutics, Inc. | 847 Thousand USD | -38999.882% |
| Kura Oncology, Inc. | -20.11 Million USD | 1746.168% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 909.207% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 4043.51% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -18079.553% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 10458.962% |
| Autolus Therapeutics plc | -186.59 Million USD | 277.48% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 771.702% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 220.081% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -866.429% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -101.484% |
| GRI Bio, Inc. | -1.79 Million USD | 18560.201% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 3786.678% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 1095.808% |
| IGM Biosciences, Inc. | -72.6 Million USD | 556.128% |
| INmune Bio, Inc. | -25.41 Million USD | 1403.278% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -119.393% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 753.736% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2138.085% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 11579.532% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -771.172% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 904.118% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -938.658% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 12.376% |
| Verastem, Inc. | -37.27 Million USD | 988.395% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 3750.127% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 738.572% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 2288.147% |
| Histogen Inc. | -7.48 Million USD | 4523.347% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 1632.738% |
| Surrozen, Inc. | -32.66 Million USD | 1113.887% |
| Organovo Holdings, Inc. | -1.5 Million USD | 22075.846% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 7978.6% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -1646.69% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -12559.633% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -7868.624% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 4051.439% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 862.341% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 2371.93% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 204.542% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 45965.441% |
| Apollomics, Inc. | -27.39 Million USD | 1308.892% |
| Amarin Corporation plc | -191.04 Million USD | 273.354% |
| Mesoblast Limited | 55.96 Million USD | -491.777% |
| Turnstone Biologics Corp. | -14.58 Million USD | 2370.817% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 1409.41% |
| Synaptogenix, Inc. | -28.66 Million USD | 1255.473% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 35482.051% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -579.586% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 38515.523% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 4657.836% |
| Exelixis, Inc. | -73.05 Million USD | 553.355% |
| Better Therapeutics, Inc. | -860 Thousand USD | 38608.837% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 1479.153% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 237.206% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -44892.704% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 4552.406% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -26309.569% |
| Gritstone bio, Inc. | 39.49 Million USD | -738.633% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 493.784% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 12682.006% |
| Avid Bioservices, Inc. | 169.72 Million USD | -95.122% |
| Insmed Incorporated | 721.62 Million USD | 54.107% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 3722.771% |
| MediWound Ltd. | -5.32 Million USD | 6322.773% |
| OmniAb, Inc. | 9.2 Million USD | -3498.566% |
| Alector, Inc. | -35.63 Million USD | 1029.304% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -285.218% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 6820.292% |
| Zai Lab Limited | -775 Million USD | 142.732% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 2.754% |
| Aura Biosciences, Inc. | -21.52 Million USD | 1638.564% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 501.523% |
| Immunic, Inc. | -45.34 Million USD | 830.428% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 271.403% |
| Veracyte, Inc. | -203.82 Million USD | 262.481% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 48.115% |
| FibroGen, Inc. | 56.76 Million USD | -483.395% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3618.989% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 11814.411% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 16096.151% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 92.785% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 10012.481% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 299.547% |
| TG Therapeutics, Inc. | 17.86 Million USD | -1754.081% |
| Galecto, Inc. | -21.21 Million USD | 1660.973% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 1492.373% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 78.898% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 1453.285% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 2978.039% |
| XBiotech Inc. | -200.02 Million USD | 265.569% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 493.784% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -7213.958% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1039.16% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 528.884% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -5719.294% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 294.335% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 458.516% |
| Vaxxinity, Inc. | 10.13 Million USD | -3168.614% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 55.02% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 3175.685% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 602.117% |
| NexImmune, Inc. | -3.13 Million USD | 10668.402% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 9691.873% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 2291.557% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 1322.052% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 3789.55% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 265944.672% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 916.267% |
| Ainos, Inc. | 4.07 Million USD | -8021.183% |
| Pluri Inc. | 22.82 Million USD | -1350.681% |
| Prothena Corporation plc | -608.34 Million USD | 154.439% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 378.871% |
| Celularity Inc. | 65.19 Million USD | -408.017% |
| Rallybio Corporation | -24.1 Million USD | 1474.06% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1079.26% |
| MeiraGTx Holdings plc | -40.3 Million USD | 921.736% |
| Humacyte, Inc. | -22.48 Million USD | 1572.81% |
| Immunocore Holdings plc | -358.59 Million USD | 192.354% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 1447.613% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 1171.732% |
| Blueprint Medicines Corporation | 702.83 Million USD | 52.88% |
| CalciMedica, Inc. | -5.53 Million USD | 6088.716% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 275.952% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 927.175% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 1095.928% |
| Pulmatrix, Inc. | -10.41 Million USD | 3279.188% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 5640.84% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 968.271% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 397.28% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 652.476% |
| Cytokinetics, Incorporated | 642.37 Million USD | 48.445% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 5787.378% |
| Nutriband Inc. | -251.65 Thousand USD | 131698.167% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1070.65% |
| Vor Biopharma Inc. | 4.3 Million USD | -7601.767% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 105.487% |
| Evogene Ltd. | -19.63 Million USD | 1786.747% |
| ProKidney Corp. | -56.23 Million USD | 688.904% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 780.424% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 3685.247% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 75.719% |
| CorMedix Inc. | -43.05 Million USD | 869.237% |
| BioLineRx Ltd. | 7.33 Million USD | -4414.395% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 1305.811% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -617.654% |
| Atai Life Sciences N.V. | -28.55 Million USD | 1259.661% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -14747.42% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 1551.508% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -1767.358% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 541.133% |
| MediciNova, Inc. | -50.78 Million USD | 752.133% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 520.247% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1472320.493% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5232.451% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 265.736% |
| Biomea Fusion, Inc. | -166.57 Million USD | 298.821% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 285.04% |
| Mereo BioPharma Group plc | -51.46 Million USD | 743.448% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 449.18% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 212.737% |
| Absci Corporation | -72.59 Million USD | 556.178% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7153.088% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 241.264% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 451.526% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 446.071% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 947.583% |
| Allakos Inc. | -24.97 Million USD | 1426.03% |
| Imunon, Inc. | -4.21 Million USD | 7959.222% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 2346.479% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 344.591% |
| BioAtla, Inc. | -109.01 Million USD | 403.801% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -44892.704% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 35369.01% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -2667.642% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 1661.93% |
| XOMA Corporation | -29 Million USD | 1241.986% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 2099.855% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 3773.203% |
| aTyr Pharma, Inc. | -7.44 Million USD | 4545.912% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 365.715% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 259.094% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 504.965% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 457.013% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 38645.411% |
| Akari Therapeutics, Plc | -3.84 Million USD | 8713.16% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20306.559% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 76.017% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 27973.6% |
| UroGen Pharma Ltd. | 4.39 Million USD | -7442.154% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -191.834% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -460109.555% |
| Orgenesis Inc. | 21.78 Million USD | -1420.272% |
| Entera Bio Ltd. | -10.62 Million USD | 3215.778% |
| GH Research PLC | -78.07 Million USD | 524.166% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 1585.894% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 1342.267% |
| Xencor, Inc. | 29.64 Million USD | -1017.177% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 16912.569% |
| Replimune Group, Inc. | 1.41 Million USD | -23354.391% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 135324.656% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 361.971% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 27973.6% |
| Portage Biotech Inc. | -4.98 Million USD | 6748.785% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 1472320.493% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 600.856% |
| OncoCyte Corporation | -6.56 Million USD | 5146.107% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -36803.41% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 7369.578% |
| Purple Biotech Ltd. | -14.13 Million USD | 2442.453% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 1494.073% |
| scPharmaceuticals Inc. | -6.54 Million USD | 5159.985% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 2084.021% |
| HilleVax, Inc. | -165.48 Million USD | 300.124% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 13148.7% |
| Tharimmune, Inc. | -10.93 Million USD | 3128.49% |
| Genprex, Inc. | -6.73 Million USD | 5015.32% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 189.797% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 474.379% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 23738.544% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 10084.365% |
| OKYO Pharma Limited | -826.84 Thousand USD | 40152.827% |
| Savara Inc. | 153 Thousand USD | -216354.902% |
| Curis, Inc. | -23.88 Million USD | 1486.428% |
| Daré Bioscience, Inc. | -5.15 Million USD | 6520.739% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 42776.66% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 5434.665% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -27847.342% |
| BeiGene, Ltd. | -2.25 Billion USD | 114.699% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -2584.086% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 154.451% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 278.449% |
| Erasca, Inc. | -37.21 Million USD | 989.875% |
| bluebird bio, Inc. | 108.57 Million USD | -205.032% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 25814.559% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 12.56% |
| DBV Technologies S.A. | -126.98 Million USD | 360.797% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 25814.559% |
| Moderna, Inc. | -2.9 Billion USD | 111.392% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 3299.15% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 3147.258% |
| Molecular Templates, Inc. | 707 Thousand USD | -46742.433% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 1155.676% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 4.452% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 503.568% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 461.033% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 1126.202% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1063.393% |
| MacroGenics, Inc. | -66.98 Million USD | 594.403% |
| RenovoRx, Inc. | -1.17 Million USD | 28333.248% |
| Adicet Bio, Inc. | -138.78 Million USD | 338.622% |
| Prime Medicine, Inc. | -27.94 Million USD | 1285.269% |
| Aditxt, Inc. | 18.12 Million USD | -1727.593% |
| Adagene Inc. | -87.62 Million USD | 477.937% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8050.588% |
| Quantum-Si incorporated | -118.55 Million USD | 379.339% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -819.806% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 4530.929% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 782.71% |
| SciSparc Ltd. | -2.06 Million USD | 16137.579% |
| Vericel Corporation | 1.27 Million USD | -25833.908% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2861.71% |
| Minerva Neurosciences, Inc. | 41 Million USD | -707.663% |
| Generation Bio Co. | 31.44 Million USD | -953.091% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 288.851% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 1170.97% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -184.044% |
| Invivyd, Inc. | -198.47 Million USD | 266.859% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 466.873% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 13912.304% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 567.829% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 4952.396% |
| 2seventy bio, Inc. | 181.71 Million USD | -82.25% |
| ADMA Biologics, Inc. | 90.06 Million USD | -267.704% |
| Clene Inc. | 3.34 Million USD | -9815.449% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 3746.227% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 1639.566% |
| GeoVax Labs, Inc. | -6.45 Million USD | 5232.451% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 196.237% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 1373.769% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -86.404% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 8194.112% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -6520.872% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 6457.765% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 354.156% |
| Evaxion Biotech A/S | 5.28 Million USD | -6164.153% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 394.201% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 352.28% |
| Trevena, Inc. | 2.25 Million USD | -14566.785% |
| Surrozen, Inc. | -32.66 Million USD | 1113.887% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 742.935% |
| Cingulate Inc. | 3.08 Million USD | -10643.109% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 11375.996% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -4507.987% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 3664.395% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 517.503% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 351.937% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 413.786% |
| Clearmind Medicine Inc. | -3.94 Million USD | 8499.86% |
| Kronos Bio, Inc. | -36.05 Million USD | 1018.556% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -3419.779% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -22612.425% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 710.395% |
| Statera Biopharma, Inc. | 14.41 Million USD | -2197.216% |
| ImmunityBio, Inc. | 618.22 Million USD | 46.431% |
| Korro Bio, Inc. | -132.94 Million USD | 349.111% |
| Kineta, Inc. | -4.54 Million USD | 7393.019% |
| BioVie Inc. | -17.73 Million USD | 1967.637% |
| Codexis, Inc. | -43.27 Million USD | 865.353% |
| Celularity Inc. | 65.19 Million USD | -408.017% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 10550.489% |
| Celcuity Inc. | 6.78 Million USD | -4782.075% |
| Virax Biolabs Group Limited | -3.36 Million USD | 9941.947% |
| Cibus, Inc. | -8.07 Million USD | 4199.728% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 7931.071% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -7146.74% |
| IN8bio, Inc. | -16.38 Million USD | 2120.721% |
| Kodiak Sciences Inc. | -103.87 Million USD | 418.822% |
| Annexon, Inc. | -193.75 Million USD | 270.925% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -919833.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 1992.542% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 9527.156% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 68.587% |
| Eyenovia, Inc. | 1.25 Million USD | -26210.914% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -1130.909% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10312.026% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 1096.108% |
| Arcellx, Inc. | -296.95 Million USD | 211.523% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 1797.816% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 662.507% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 1697.8% |
| Moolec Science SA | 117.61 Thousand USD | -281473.936% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 962.46% |
| Geron Corporation | 14.76 Million USD | -2143.588% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 973.4% |
| Royalty Pharma plc | 5.65 Billion USD | 94.147% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 334.177% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 4838.245% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 6275.363% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 335.326% |
| Humacyte, Inc. | -22.48 Million USD | 1572.81% |
| Structure Therapeutics Inc. | -124.33 Million USD | 366.349% |
| 89bio, Inc. | -289.05 Million USD | 214.573% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 1412.004% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 18674.089% |
| Genelux Corporation | -6.89 Million USD | 4900.348% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 1166.28% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -296.148% |
| Notable Labs, Ltd. | -9.77 Million USD | 3487.643% |
| Liquidia Corporation | -80.17 Million USD | 513.061% |
| Mustang Bio, Inc. | -3.73 Million USD | 8964.454% |
| Immunovant, Inc. | -635.22 Million USD | 152.135% |
| Quantum-Si incorporated | -118.55 Million USD | 379.339% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 1985.539% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 8093.628% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -4025.776% |
| Acasti Pharma Inc. | -23 Million USD | 1539.583% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 9935.268% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 2138.085% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 340.436% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 10727.007% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 1589.637% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 1883.489% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 295.64% |
| PepGen Inc. | -60.67 Million USD | 645.865% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 1541.4% |
| United Therapeutics Corporation | -507.7 Million USD | 165.231% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 1831.549% |
| Solid Biosciences Inc. | -47.75 Million USD | 793.562% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 38515.523% |
| Immuneering Corporation | -54.94 Million USD | 702.764% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 7978.6% |
| Silo Pharma, Inc. | -3.52 Million USD | 9496.909% |
| Belite Bio, Inc | -87.27 Million USD | 479.48% |
| XOMA Corporation | -29 Million USD | 1241.986% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 568.444% |
| Bionomics Limited | 227 Million USD | -45.886% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 384.804% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13174.457% |
| uniQure N.V. | -102.95 Million USD | 421.683% |
| Cassava Sciences, Inc. | -121.13 Million USD | 373.392% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 8050.588% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -708.713% |
| Forte Biosciences, Inc. | -11.96 Million USD | 2868.799% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 10803.122% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -312330.189% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 10312.026% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -3618.989% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 4565.696% |
| Altimmune, Inc. | -134.48 Million USD | 346.251% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -67.206% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 13174.457% |
| Compugen Ltd. | -12.9 Million USD | 2666.46% |
| Peak Bio, Inc. | 10.34 Million USD | -3102.814% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 117123.322% |
| Benitec Biopharma Inc. | -50.58 Million USD | 754.731% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 417.407% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -1585.803% |
| Zura Bio Limited | -99.8 Million USD | 431.82% |
| PolyPid Ltd. | 6.17 Million USD | -5267.52% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -346.811% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -1585.803% |
| Instil Bio, Inc. | 75.35 Million USD | -339.47% |
| argenx SE | -2.02 Billion USD | 116.323% |
| Immunome, Inc. | -97.02 Million USD | 441.317% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 1572.22% |
| Verona Pharma plc | -220.44 Million USD | 250.232% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 561.614% |
| Shattuck Labs, Inc. | -121.42 Million USD | 372.743% |
| CervoMed Inc. | -7.79 Million USD | 4349.744% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 278.532% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 7673.199% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 351.386% |
| Moolec Science SA | 117.61 Thousand USD | -281473.936% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 14574.621% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -1983.08% |
| AnaptysBio, Inc. | -18.15 Million USD | 1924.561% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1924.661% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 570.547% |
| NeurAxis, Inc. | 145.7 Thousand USD | -227199.931% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -2848.504% |
| Lumos Pharma, Inc. | -28.49 Million USD | 1262.307% |
| Achilles Therapeutics plc | -126.92 Million USD | 360.925% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 561.614% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 50604.933% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 1694.198% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -22612.425% |
| Nutriband Inc. | -251.65 Thousand USD | 131698.167% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 2614.433% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 4551.29% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 2.652% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -1295.307% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 174.011% |
| Palisade Bio, Inc. | -12.06 Million USD | 2845.387% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 336.03% |
| Beam Therapeutics Inc. | -262.72 Million USD | 226.056% |
| Neurogene Inc. | -131.95 Million USD | 350.976% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -1418.042% |
| AEON Biopharma, Inc. | -4.88 Million USD | 6886.393% |
| Sesen Bio, Inc. | -112.55 Million USD | 394.24% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 431.64% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 14205.843% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 948.603% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 497.656% |
| Athira Pharma, Inc. | -88.99 Million USD | 472.112% |
| Vaccinex, Inc. | -1.28 Million USD | 25812.422% |
| HCW Biologics Inc. | 2.85 Million USD | -11493.054% |
| XOMA Corporation | -29 Million USD | 1241.986% |
| Nektar Therapeutics | 210.24 Million USD | -57.523% |
| Arvinas, Inc. | -313.8 Million USD | 205.537% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -20306.559% |
| Merus N.V. | -192.88 Million USD | 271.697% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -452.098% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 4873.364% |
| Rezolute, Inc. | -68.16 Million USD | 585.823% |
| Clene Inc. | 3.34 Million USD | -9815.449% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 2611.382% |
| BeyondSpring Inc. | -13.75 Million USD | 2507.677% |
| Synlogic, Inc. | -6.68 Million USD | 5054.016% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -29104.233% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 4016.925% |
| Peak Bio, Inc. | 10.34 Million USD | -3102.814% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 501.815% |
| Krystal Biotech, Inc. | -350.23 Million USD | 194.558% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -166.808% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 295.967% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 10589.734% |
| MannKind Corporation | 143.89 Million USD | -130.145% |
| Ikena Oncology, Inc. | -109.15 Million USD | 403.397% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 4474.27% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 1100.532% |
| Gossamer Bio, Inc. | 180.35 Million USD | -83.625% |
| CohBar, Inc. | -5.93 Million USD | 5684.067% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 1213.271% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -7153.088% |
| Legend Biotech Corporation | -949.39 Million USD | 134.883% |
| Mural Oncology plc | -255.84 Million USD | 229.445% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -928.018% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 7130.379% |
| Disc Medicine, Inc. | -358.28 Million USD | 192.435% |
| Champions Oncology, Inc. | 4.81 Million USD | -6782.294% |
| REGENXBIO Inc. | 54.76 Million USD | -504.689% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 123256.333% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 319.287% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 3774.831% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 510.466% |
| Vaxart, Inc. | -8.24 Million USD | 4118.639% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 759.977% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 360.429% |
| Cellectis S.A. | -43.85 Million USD | 855.161% |
| Longeveron Inc. | -2.9 Million USD | 11488.446% |
| Repare Therapeutics Inc. | -107.85 Million USD | 407.048% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 65.801% |
| Inozyme Pharma, Inc. | 12 Million USD | -2658.88% |
| Revolution Medicines, Inc. | -608.2 Million USD | 154.451% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 27024.878% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 224.917% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 320.678% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 2216.546% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 44853.514% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 103.463% |
| Denali Therapeutics Inc. | -74.86 Million USD | 542.364% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 2861.71% |
| Veru Inc. | 4.77 Million USD | -6828.413% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 3044.834% |
| Cingulate Inc. | 3.08 Million USD | -10643.109% |
| Passage Bio, Inc. | 4.58 Million USD | -7123.032% |
| Context Therapeutics Inc. | -14.44 Million USD | 2391.903% |
| Exicure, Inc. | 5.84 Million USD | -5562.096% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 243.755% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 936.937% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -2010.611% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 663.023% |
| Nuvalent, Inc. | -335.38 Million USD | 198.744% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -18995.207% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 544.639% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 3825.264% |
| OmniAb, Inc. | 9.2 Million USD | -3498.566% |
| Anew Medical, Inc. | 1.43 Million USD | -23019.308% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -1921.615% |
| Lipocine Inc. | -4.75 Million USD | 7065.393% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 401.541% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -2074.355% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 753.736% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -1230.452% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 5027.481% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 603.101% |
| Ocugen, Inc. | -32.52 Million USD | 1118.345% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 487.001% |
| Q32 Bio Inc. | -37.94 Million USD | 972.71% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 52835.032% |
| Alumis Inc. Common Stock | -13.52 Million USD | 2547.897% |
| Equillium, Inc. | -22.39 Million USD | 1578.992% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 1395.275% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 1115.044% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 133684.495% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -147.069% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -10255.722% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -100732.722% |
| Dominari Holdings Inc. | 195 Thousand USD | -169733.846% |
| Edesa Biotech, Inc. | -5.26 Million USD | 6387.861% |
| vTv Therapeutics Inc. | -8.91 Million USD | 3813.985% |
| Bio-Techne Corporation | 267.74 Million USD | -23.69% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 2143.161% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 380.434% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 4041.164% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 2717.785% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 235.108% |
| Nkarta, Inc. | 57.29 Million USD | -477.979% |
| BioCardia, Inc. | 212 Thousand USD | -156115.094% |
| Iterum Therapeutics plc | 13.43 Million USD | -2364.474% |